General Information of the Compound
| Compound ID |
CP0528376
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(5R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-3-oxo-17-[(2R)-2,6,6-trimethyloxan-2-yl]-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-yl] 2-[5-(1,3-benzodioxol-5-yl)tetrazol-1-yl]acetate
Show/Hide
|
||||||||||||||||||
| Formula |
C40H56N4O6
|
||||||||||||||||||
| Molecular Weight |
688.91
|
||||||||||||||||||
| Canonical SMILES |
C[C@@]12CC[C@@H]([C@H]1[C@@H](C[C@@H]1[C@@]3(C)CCC(=O)C(C)(C)[C@@H]3CC[C@@]21C)OC(=O)Cn1nnnc1-c1ccc2OCOc2c1)[C@@]1(C)CCCC(C)(C)O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H56N4O6/c1-35(2)15-9-16-40(8,50-35)25-12-18-39(7)33(25)28(21-30-37(5)17-14-31(45)36(3,4)29(37)13-19-38(30,39)6)49-32(46)22-44-34(41-42-43-44)24-10-11-26-27(20-24)48-23-47-26/h10-11,20,25,28-30,33H,9,12-19,21-23H2,1-8H3/t25-,28+,29-,30+,33-,37-,38+,39+,40+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UATKQINXQCVKGH-NTQKMEGHSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound